Eli Lilly & Company

Venture Capital

Corporate venture arm of Eli Lilly investing in early-stage biotech, immunology, oncology, cardio-metabolic, and neuroscience globally.

Indianapolis, United States · 3+ investments · 2 portfolio companies

Seed
Early Stage
Biotech
Digital Health
Headquarters
Indianapolis, United States
Portfolio Companies
2
Total Investments
3
Last Investment
Oct 2025
Geographic Focus
Global

Investment Thesis

Strategic CVC investing in emerging biotech science across immunology, oncology, cardio-metabolic, and neuroscience. Targets seed and Series A syndicated rounds, backing ~10-15 companies annually to bridge external innovation into Lilly's pipeline.

Eli Lilly & Company is a Venture Capital firm based in Indianapolis, United States. It has made 3 investments, including Affinia Therapeutics and Zephyr AI. Focus areas include Biotech and Digital Health.

Portfolio2

Co-investors24

Sign up to view co-investors

24 co-investors across 18 shared portfolio companies — who they back alongside, and how often they lead.

Venture Capital ×18 · Hedge Fund ×2 · Growth Equity ×1 · 10 shared rounds

Investment History

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

Eli Lilly & Company on Indexed.vc
<a href="https://indexed.vc/investors/eli-lilly-company"><img src="https://indexed.vc/api/badge/investor/eli-lilly-company" alt="Eli Lilly & Company on Indexed.vc" width="260" height="76" /></a>